Nicholson Donald William 4
4 · Kymera Therapeutics, Inc. · Filed Jun 16, 2022
Insider Transaction Report
Form 4
Nicholson Donald William
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-15+12,000→ 12,000 totalExercise: $14.18Exp: 2032-06-14→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 15, 2023 and (ii) the date of the next annual meeting of the Issuer's stockholders.